ABAT Overexpression Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Mitochondrial Homeostasis
- 1School of Pharmacy, Bengbu Medical University, Bengbu 233030, China
- 2Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, Bengbu 233030, China
Abstract
Doxorubicin is a widely used chemotherapeutic agent whose clinical application is limited by dose-dependent cardiotoxicity, with mitochondrial dysfunction being a central pathological mechanism. Gamma-aminobutyric acid transaminase (ABAT) is a mitochondrial matrix enzyme implicated in mitochondrial DNA (mtDNA) maintenance through its role in the salvage synthesis of deoxyribonucleotides (dNTPs). However, whether ABAT exerts a protective role against doxorubicin-induced cardiotoxicity remains unknown. Here, we investigated the effect of ABAT overexpression on doxorubicin-induced cardiac injury and explored the underlying mechanisms. We found that ABAT expression and enzymatic activity were significantly reduced in the myocardium of doxorubicin-treated mice. Using cardiomyocyte-specific ABAT transgenic mice, we demonstrated that ABAT overexpression ameliorated doxorubicin-induced cardiac dysfunction, as evidenced by improved ejection fraction and fractional shortening, reduced serum levels of cardiac injury markers, and alleviated myocardial fibrosis and cardiomyocyte atrophy. Mechanistically, ABAT overexpression reversed doxorubicin-induced mtDNA depletion, restored mitochondrial respiratory chain complex activity, and improved oxygen consumption rate and ATP production, accompanied by reduced cellular and mitochondrial reactive oxygen species levels. Furthermore, doxorubicin triggered the initiation of mitophagy, as reflected by the accumulation of phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) and Parkin, but did not sustain autophagic degradation, as reflected by a markedly blunted bafilomycin A1-induced accumulation of microtubule-associated protein 1 light chain 3 beta II (LC3B-II) so that autophagic structures containing mitochondria accumulated; ABAT overexpression attenuated these changes, partially restoring the responsiveness of LC3B-II to bafilomycin A1. Complementary in vitro experiments using ABAT-overexpressing H9c2 cells confirmed that ABAT attenuated doxorubicin-induced lactate dehydrogenase (LDH) release, caspase-3 activation, and apoptosis. Taken together, our findings demonstrate that ABAT overexpression protects against doxorubicin-induced cardiotoxicity and is associated with preservation of mtDNA and mitochondrial function, reduced oxidative stress, and a reduced burden of damaged mitochondria. Given the reported antitumor properties of ABAT, these findings provide a basis for further investigating ABAT as a potential therapeutic target for mitigating doxorubicin-induced cardiotoxicity.
Related
- Mitofusin-2 overexpression in adipose tissue-derived mesenchymal stem cells protects the testis against testicular torsion-induced ischemia-reperfusion injury through preservation of mitochondrial homeostasis associated with AMPK activation.
- Hepatocyte Serine Palmitoyltransferase 3 is essential for mitochondrial ceramide homeostasis and electron transport chain function
- Insight of the role of mitochondrial iron homeostasis in insulin resistance
- Natural polysaccharides as modulators of mitochondrial homeostasis: structural determinants, pharmacological mechanisms, and translational challenges
- MASLD-Mitochondrial Digital Twin: Mapping mitonuclear epistasis to predict disease trajectory and systemic bioenergetic homeostasis
BibTeX
@article{yang2026abat,
title = {{ABAT Overexpression Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Mitochondrial Homeostasis}},
author = {Peng Yang and Rong Yang and Jingjing Guo and Aonan Yu and Xinyu Liu and Mengxiao Zhang},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms27219994},
url = {https://www.mdpi.com/1422-0067/27/21/9994},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - ABAT Overexpression Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Mitochondrial Homeostasis
AU - Peng Yang
AU - Rong Yang
AU - Jingjing Guo
AU - Aonan Yu
AU - Xinyu Liu
AU - Mengxiao Zhang
PY - 2026
DA - 2026/11/07
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219994
UR - https://www.mdpi.com/1422-0067/27/21/9994
AB - Doxorubicin is a widely used chemotherapeutic agent whose clinical application is limited by dose-dependent cardiotoxicity, with mitochondrial dysfunction being a central pathological mechanism. Gamma-aminobutyric acid transaminase (ABAT) is a mitochondrial matrix enzyme implicated in mitochondrial DNA (mtDNA) maintenance through its role in the salvage synthesis of deoxyribonucleotides (dNTPs). However, whether ABAT exerts a protective role against doxorubicin-induced cardiotoxicity remains unknown. Here, we investigated the effect of ABAT overexpression on doxorubicin-induced cardiac injury and explored the underlying mechanisms. We found that ABAT expression and enzymatic activity were significantly reduced in the myocardium of doxorubicin-treated mice. Using cardiomyocyte-specific ABAT transgenic mice, we demonstrated that ABAT overexpression ameliorated doxorubicin-induced cardiac dysfunction, as evidenced by improved ejection fraction and fractional shortening, reduced serum levels of cardiac injury markers, and alleviated myocardial fibrosis and cardiomyocyte atrophy. Mechanistically, ABAT overexpression reversed doxorubicin-induced mtDNA depletion, restored mitochondrial respiratory chain complex activity, and improved oxygen consumption rate and ATP production, accompanied by reduced cellular and mitochondrial reactive oxygen species levels. Furthermore, doxorubicin triggered the initiation of mitophagy, as reflected by the accumulation of phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) and Parkin, but did not sustain autophagic degradation, as reflected by a markedly blunted bafilomycin A1-induced accumulation of microtubule-associated protein 1 light chain 3 beta II (LC3B-II) so that autophagic structures containing mitochondria accumulated; ABAT overexpression attenuated these changes, partially restoring the responsiveness of LC3B-II to bafilomycin A1. Complementary in vitro experiments using ABAT-overexpressing H9c2 cells confirmed that ABAT attenuated doxorubicin-induced lactate dehydrogenase (LDH) release, caspase-3 activation, and apoptosis. Taken together, our findings demonstrate that ABAT overexpression protects against doxorubicin-induced cardiotoxicity and is associated with preservation of mtDNA and mitochondrial function, reduced oxidative stress, and a reduced burden of damaged mitochondria. Given the reported antitumor properties of ABAT, these findings provide a basis for further investigating ABAT as a potential therapeutic target for mitigating doxorubicin-induced cardiotoxicity.
SN - 1422-0067
ER -